Victor H Obungu

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene
    Karen E Sukhodolets
    Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 1802, USA
    Mol Cell Biol 23:493-509. 2003
  2. ncbi Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling
    Victor H Obungu
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Biochemistry 48:7251-60. 2009
  3. ncbi Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain
    Victor H Obungu
    Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Oncogene 22:6347-58. 2003
  4. ncbi Molecular pathology of the MEN1 gene
    Sunita K Agarwal
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann N Y Acad Sci 1014:189-98. 2004
  5. ncbi Epitope mapping of antibodies by mass spectroscopy: a case study
    Victor H Obungu
    Lilly Research Laboratories, Indianapolis, IN, USA
    Methods Mol Biol 988:291-302. 2013

Collaborators

Detail Information

Publications5

  1. ncbi The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene
    Karen E Sukhodolets
    Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 1802, USA
    Mol Cell Biol 23:493-509. 2003
    ..This finding was consistent with the extensive overlap in the nuclear localization patterns of endogenous menin, RPA2, and RPA1 observed by immunofluorescence...
  2. ncbi Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling
    Victor H Obungu
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Biochemistry 48:7251-60. 2009
    ..Furthermore, through molecular homology modeling, we have proposed a mechanism for the neutralizing activity of this antibody that involves interference with the docking of the ligand to its receptor by the antibody...
  3. ncbi Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain
    Victor H Obungu
    Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Oncogene 22:6347-58. 2003
    ..These data indicate that menin through binding to NMHC II-A could participate in cell division and in other processes that involve NMHC II-A...
  4. ncbi Molecular pathology of the MEN1 gene
    Sunita K Agarwal
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann N Y Acad Sci 1014:189-98. 2004
    ..The Men1+/- mouse has robust MEN1; its most important difference from human MEN1 is marked hyperplasia of pancreatic islets, a tumor precursor stage...
  5. ncbi Epitope mapping of antibodies by mass spectroscopy: a case study
    Victor H Obungu
    Lilly Research Laboratories, Indianapolis, IN, USA
    Methods Mol Biol 988:291-302. 2013
    ..Such methods include epitope extortion/excision, hydrogen deuterium exchange...